Most platforms require you to complete laboratory work either through their partner labs or by uploading recent results from your primary care physician
Recent Major Changes Indications and Usage for Vyvanse VYVANSE is a central nervous system (CNS) stimulant indicated for the treatment of (1): Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older Moderate to severe binge eating disorder (BED) in adults Limitations of Use: The use of VYVANSE is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage (5.5, 8.4) VYVANSE is not indicated for weight loss
Garcia, Rotating injection sites and using the proper technique (e.g., injecting at a 90-degree angle and applying gentle pressure after the injection) can help reduce the risk of bruising. Switch up the site with every injection so you dont disrupt the same blood vessels over and over
Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1-7 trials
The reduced overhead of virtual clinics can translate to cost savings for patients, especially those without insurance coverage
